First-Line Treatment for Pediatric ADHD

Age-Specific Treatment Recommendations

For pediatric patients with ADHD, the American Academy of Pediatrics recommends evidence-based parent and/or teacher-administered behavioral therapy for preschool children (ages 4-5), and FDA-approved medications combined with behavioral interventions for elementary school-aged children (ages 6-12) and adolescents (ages 12-18) 1, 2, 3
The American Academy of Pediatrics suggests that evidence-based parent training in behavior management (PTBM) and/or behavioral classroom interventions should be prescribed as first-line treatment for preschool children (ages 4-5) 3, 4
For elementary and middle school-aged children (ages 6-12), the American Academy of Pediatrics recommends FDA-approved medications for ADHD along with PTBM and/or behavioral classroom interventions (preferably both) 5, 3
The American Academy of Pediatrics recommends that educational interventions and individualized instructional supports are a necessary part of any treatment plan for elementary and middle school-aged children (ages 6-12) and adolescents (ages 12-18) 3, 7

The American Academy of Pediatrics recommends that FDA-approved medications for ADHD with the adolescent's assent are recommended for adolescents (ages 12-18) 3, 8

The American Academy of Pediatrics suggests that behavioral parent training involves teaching parents behavior-modification principles for implementation in home settings 1
The American Academy of Pediatrics recommends that training interventions target skill development and involve repeated practice with performance feedback over time 9

The American Academy of Pediatrics recognizes ADHD as a chronic condition requiring ongoing management following principles of the chronic care model 3, 4
The American Academy of Pediatrics recommends that medication doses should be titrated to achieve maximum benefit with minimum adverse effects 1
The American Academy of Pediatrics suggests that screening for comorbid conditions (anxiety, depression, learning disorders, etc.) is essential for developing appropriate treatment plans 1, 3

The American Academy of Pediatrics recommends that failing to screen for comorbid conditions that may complicate treatment should be avoided 1, 3
The American Academy of Pediatrics suggests that starting medications in preschoolers without first trying behavioral interventions should be avoided 3, 6
The American Academy of Pediatrics recommends that not involving both home and school environments in behavioral interventions should be avoided 9, 7
The American Academy of Pediatrics suggests that discontinuing treatment prematurely should be avoided, as the positive effects of behavioral therapies tend to persist, while medication effects cease when medication stops 9, 7
The American Academy of Pediatrics recommends that not recognizing ADHD as a chronic condition requiring ongoing management and periodic reevaluation should be avoided 3, 4